Sarepta Therapeutics

$71.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.83 (-1.14%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SRPT and other stocks, options, and ETFs commission-free!

About SRPT

Sarepta Therapeutics, Inc. Common Stock (DE), also called Sarepta Therapeutics, is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases.

CEO

Douglas S. Ingram

Employees

866

Headquarters

Cambridge, Massachusetts

Founded

1980

Market Cap

5.50B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

855.76K

High Today

$73.00

Low Today

$70.73

Open Price

$72.41

Volume

670.35K

52 Week High

$181.83

52 Week Low

$68.04

Analyst Ratings

64%

of 22 ratings

Buy

64%

Hold

32%

Sell

SRPT Earnings

-$1.86

-$1.24

-$0.62

-$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, After Hours